TD Asset Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

TD Asset Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-60,739	Closed	-$1.74M	–	1485
2023 Q1	$1.74M	Hold	60,739	–	–	﹤0.01%	1014
2022 Q4	$1.9M	Buy	60,739 +3,513	+6%	+$115K	﹤0.01%	1007
2022 Q3	$1.12M	Hold	57,226	–	–	﹤0.01%	1157
2022 Q2	$888K	Hold	57,226	–	–	﹤0.01%	1203
2022 Q1	$1.09M	Buy	57,226 +9,800	+21%	+$175K	﹤0.01%	1218
2021 Q4	$1.2M	Buy	47,426 +6,600	+16%	+$193K	﹤0.01%	1243
2021 Q3	$1.34M	Buy	+40,826	New	+$1.39M	﹤0.01%	1190

Other funds holding DICE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

TD Asset Management's DICE Position: Q2 2023 in Review

TD Asset Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q2 2023, closing a stake of 60,739 shares — an estimated $1.74M sold.

TD Asset Management first reported a position in DICE in Q3 2021 and held it in 7 quarters. The position peaked at $1.9M in Q4 2022. 160 funds tracked by Wall St. Rank hold DICE as of Q2 2023.

TD Asset Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
TD Asset Management sold 60,739 DICE Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $1.74M.
TD Asset Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
TD Asset Management's DICE Therapeutics, Inc. Common Stock position peaked at $1.9M in Q4 2022.
160 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q2 2023.

Based on TD Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.